athenahealth, Inc (NASDAQ:ATHN) has earned a consensus recommendation of “Hold” from the twenty-two analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eighteen have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $147.82.

A number of equities analysts recently weighed in on the stock. Canaccord Genuity lowered their target price on shares of athenahealth from $160.00 to $135.00 and set a “hold” rating for the company in a research note on Tuesday, November 13th. Leerink Swann set a $138.00 target price on shares of athenahealth and gave the stock a “hold” rating in a research note on Thursday, November 1st. William Blair reissued a “market perform” rating on shares of athenahealth in a research note on Monday, November 12th. SunTrust Banks lowered their target price on shares of athenahealth to $150.00 in a research note on Wednesday, September 19th. Finally, Robert W. Baird downgraded shares of athenahealth from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $160.00 to $135.00 in a research note on Monday, November 12th.

In other athenahealth news, insider Daniel P. Haley sold 2,204 shares of athenahealth stock in a transaction on Monday, October 1st. The shares were sold at an average price of $127.23, for a total value of $280,414.92. Following the completion of the sale, the insider now directly owns 10,555 shares of the company’s stock, valued at $1,342,912.65. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last ninety days, insiders sold 2,654 shares of company stock valued at $340,770. Insiders own 2.90% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of ATHN. Jane Street Group LLC bought a new stake in athenahealth in the first quarter valued at $234,000. Guggenheim Capital LLC increased its stake in athenahealth by 16.9% in the first quarter. Guggenheim Capital LLC now owns 2,980 shares of the health services provider’s stock valued at $426,000 after purchasing an additional 430 shares in the last quarter. Royal Bank of Canada increased its stake in athenahealth by 15.8% in the first quarter. Royal Bank of Canada now owns 25,646 shares of the health services provider’s stock valued at $3,670,000 after purchasing an additional 3,505 shares in the last quarter. State of Alaska Department of Revenue increased its stake in athenahealth by 32.2% in the second quarter. State of Alaska Department of Revenue now owns 4,800 shares of the health services provider’s stock valued at $763,000 after purchasing an additional 1,170 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in athenahealth in the second quarter valued at $206,000.

Shares of NASDAQ:ATHN traded up $0.20 during mid-day trading on Monday, reaching $131.61. 1,871,003 shares of the company’s stock were exchanged, compared to its average volume of 621,758. The firm has a market cap of $5.34 billion, a PE ratio of 83.83, a price-to-earnings-growth ratio of 2.38 and a beta of 0.80. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.74 and a current ratio of 2.74. athenahealth has a twelve month low of $116.77 and a twelve month high of $163.94.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Friday, November 9th. The health services provider reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.10. athenahealth had a net margin of 9.57% and a return on equity of 15.35%. The company had revenue of $331.40 million for the quarter, compared to analyst estimates of $336.98 million. During the same quarter in the previous year, the business earned $0.56 earnings per share. athenahealth’s revenue was up 8.8% compared to the same quarter last year. Sell-side analysts forecast that athenahealth will post 3.21 EPS for the current year.

About athenahealth

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Recommended Story: Stop Order

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.